New drug duo slashes bad cholesterol in high-risk patients by nearly 49%
New Atlas - 18-May-2025Combo of ezetimibe and obicetrapib shows major LDL drop in Cleveland Clinic trial
Join the club for FREE to access the whole archive and other member benefits.
Cardiologist at the Cleveland Clinic
Dr. Ashish Sarraju is a board-certified cardiologist at the Cleveland Clinic, specializing in preventive cardiology, cardiovascular risk assessment, hyperlipidemia, and hypertension. He is particularly focused on helping patients with genetic risk factors or family histories of heart disease manage their cardiovascular health through personalized care plans.
Dr. Sarraju earned his medical degree from Northwestern University Feinberg School of Medicine in 2014. He completed his internal medicine residency and served as chief medical resident at Stanford University, followed by a fellowship in cardiovascular medicine, where he was also chief fellow. Before joining the Cleveland Clinic in 2022, he worked at Stanford as a cardiologist and Clinical Scholar in cardiovascular medicine .
Visit website: https://my.clevelandclinic.org/staff/30325-ashish-sarraju
Details last updated 20-May-2025
Combo of ezetimibe and obicetrapib shows major LDL drop in Cleveland Clinic trial